|
|
Clinical effect of bronchoscope combined with non-invasive positive pressure ventilation in the treatment of chronic obstructive pulmonary disease with respiratory failure |
ZHANG Nan |
Department of Critical Care Medicine,Iron Coal General Hospital of Liaojian Group,Liaoning Province,Tieling 112700,China |
|
|
Abstract Objective To investigate the clinical effect of patients with chronic obstructive pulmonary disease(COPD)and respiratory failure receiving bronchoscopy combined with non-invasive positive pressure ventilation(NPPV).Methods A total of 74 patients with COPD and respiratory failure admitted to the Iron Coal General Hospital of Liaojian Group from July 2018 to November 2020 were selected as the research objects,and they were divided into the control group(37 cases)and the observation group(37 cases)according to a random number table methods.The control group was treated with NPPV,and the observation group was treated with bronchoscope on the basis of the control group.The arterial blood gas indexes(arterial partial pressure of carbon dioxide[PaCO2],arterial partial pressure of oxygen[PaO2],pH),lung function(total lung capacity[TLC],forced expiratory volume in one second[FEV1]/forced vital capacity[FVC],FVC)of the two groups were compared.Results There was no significant difference in the levels of PaCO2,PaO2,pH,TLC,FEV1/FVC,FVC between the two groups before treatment(P>0.05).The level of PaCO2 of the observation group after 2 weeks of treatment was lower than that of the control group,and the levels of PaO2,pH,TLC,FEV1/FVC,FVC of the observation group after 2 weeks of treatment were all higher than those of the control group,the differences were statistically significant(P<0.05).Conclusion Bronchoscope and NPPV in the treatment of patients with COPD and respiratory failure can enhance the efficacy,and improve the blood gas indicators and lung function of patients as soon as possible.It is worthy of promotion.
|
|
|
|
|
[1] |
杨芳英.无创正压通气与HFNC 治疗对慢阻肺急性加重期伴呼吸衰竭患者气管插管率及血钠、血钾水平的影响[J].医学理论与实践,2020,33(19):3191-3193.
|
[2] |
尚根,邓艳.支气管镜下肺泡灌洗联合无创正压通气治疗慢性阻塞性肺疾病伴呼吸衰竭的临床效果[J].临床医学研究与实践,2020,5(25):44-46.
|
[3] |
肖庆.布地奈德联合无创正压通气治疗慢性阻塞性肺疾病合并呼吸衰竭患者的临床效果[J].中国民康医学,2020,32(16):47-49.
|
[4] |
杨威.纤维支气管镜肺泡灌洗联合无创正压通气治疗慢性阻塞性肺疾病急性加重期合并Ⅱ型呼吸衰竭的临床疗效及安全性研究[J].中国医疗器械信息,2020,26(15):94-95.
|
[5] |
谷书强.支气管镜联合无创正压通气治疗慢性阻塞性肺疾病呼吸衰竭的临床效果[J].慢性病学杂志,2020,21(4):517-520.
|
[6] |
李占东.支气管镜联合无创正压通气治疗慢性阻塞性肺疾病伴呼吸衰竭的临床效果分析[J].中国现代药物应用,2019,13(22):42-43.
|
[7] |
靳小利.无创正压通气联合支气管镜治疗慢性阻塞性肺疾病伴呼吸衰竭患者的疗效[J].中国民康医学,2019,31(15):38-40.
|
[8] |
罗彬,周静,秦蓁.无创正压通气联合纤维支气管镜吸痰治疗慢性阻塞性肺疾病并呼吸衰竭的临床效果[J].临床合理用药杂志,2019,12(21):3-4,7.
|
[9] |
侯红梅,肖芸,谢俊玲.体外膈肌起搏器联合无创通气治疗慢性阻塞性肺疾病的临床研究[J].中国医学创新,2019,16(16):143-146.
|
[10] |
郭庆,李静静,田青,等.纳美芬与纳洛酮联合无创正压通气治疗慢性阻塞性肺疾病并Ⅱ型呼吸衰竭患者临床疗效的对比研究及卫生经济学评价[J].实用心脑肺血管病杂志,2019,27(3):71-74.
|
[11] |
顾磊.无创正压通气与支气管镜联用治疗慢性阻塞性肺疾病合并呼吸衰竭的临床评价[J].中国医疗器械信息,2019,25(8):28-29.
|
[12] |
邓睿,梁红卫,唐欣慧.无创正压通气联合纤维支气管镜下肺泡灌洗治疗慢性阻塞性肺疾病合并严重呼吸衰竭的疗效研究[J].广西医科大学学报,2019,36(2):250-253.
|
[13] |
于海建,王灿良.支气管镜联合无创正压通气治疗慢性阻塞性肺疾病并呼吸衰竭的效果观察[J].慢性病学杂志,2018,19(12):1755-1757.
|
[14] |
李金维,刘凤琼.支气管镜联合无创正压通气治疗慢性阻塞性肺疾病合并呼吸衰竭患者的临床疗效[J].系统医学,2018,3(12):57-59.
|
[15] |
房开宇,张妍,朱虹.慢性阻塞性肺疾病合并呼吸衰竭采用纤维支气管镜联合无创正压通气治疗的临床疗效[J].中国医疗器械信息,2018,24(3):91-92.
|
[16] |
李海波.纳洛酮联合无创正压通气治疗慢性阻塞性肺疾病并发呼吸衰竭临床效果[J].中外医学研究,2018,16(3):32-33.
|
|
|
|